documents: FDA-1976-N-0027-0197
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1976-N-0027-0197 | FDA | FDA-1976-N-0027 | Supplemnet from Consumer Healthcare Products Association - Appendix 5 - Meta-analysis of Phenylephrine vs. Placebo, Analysis of Change from Baseline Nasal Airflow Resistance and LN of Ratio (Post-baseline NAR/Baseline NAR); Standard Error of Treatment Response and Upper and Lower 95% Confidence Limits on Treatment Response by Time Point and Model | Other | Supplement (SUP) | 2008-10-20T04:00:00Z | 2008 | 10 | 2015-12-14T21:45:48Z | 0 | 0 | 090000648051b937 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref